EULAR 2022 | OTHER ACCREDITATIONS
Following EULAR's application for MedTech Europe accreditation for EULAR 2022, the EULAR 2022 European Congress of Rheumatology event has been granted the status compliant.
Official Italian Agency for AIFA Procedure
Any Italian pharmaceutical company supporting or participating in a congress abroad, is subjected to an authorization by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124).
The request of authorization must be submitted within 60 days before the starting date of the event. The appointed agency to collect all applications from pharmaceutical companies and file them with the AIFA is: